{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T04:55:38Z","timestamp":1760244938432},"reference-count":34,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2006,4,27]],"date-time":"2006-04-27T00:00:00Z","timestamp":1146096000000},"content-version":"vor","delay-in-days":4103,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cutan Pathol"],"published-print":{"date-parts":[[1995,2]]},"abstract":"<jats:p>The B\u2010cell leukemia\/lymphoma gene (bcl\u20102) produces a unique protein product (BCLP) that is believed to protect lymphoid cells from apoptosis. The bcl\u20102 gene is frequently rearranged in nodal follicular lymphomas as well as in diffuse lymphoproliferations, but has generally been regarded as most useful in the recognition of the former of these lesions. However, little is known regarding BCLP expression in cutaneous lymphoid infiltrates. Using an immunohistochemical technique and a monoclonal antibody (clone no. 124) the authors examined 67 examples of cutaneous lymphoid infiltrates \u2013 31 cases of malignant lymphoma of the skin (MLS) and 36 examples of cutaneous lymphoid hyperplasias (CLH) \u2013 to determine if patterns of BCLP reactivity could distinguish CLH from MLS or primary from secondary involvement of the skin by malignant lymphoma. Fifty\u2010eight per cent of MLS cases were BCL\u2010positive, as were 33% of CLH. Three of four cases of follicular cutaneous lymphoma showed BCLP\u2010positivity in neoplastic follicles, whereas similar structures in cases of CLH with a follicular pattern were BCLP\u2010negative. Sixty per cent of primary MLSs and 57% of secondary lymphomas were reactive for BCLP. These data suggest that immunostains for BCLP are of little help in the separation of benign from malignant cutaneous lymphoid infiltrates, and that they are likewise incapable of separating primary from secondary MLS. BCLP immunostains may have a limited adjuvant diagnostic role in distinguishing reactive from neoplastic follicular lymphoid lesions of the skin.<\/jats:p>","DOI":"10.1111\/j.1600-0560.1995.tb00732.x","type":"journal-article","created":{"date-parts":[[2006,4,28]],"date-time":"2006-04-28T17:48:54Z","timestamp":1146246534000},"page":"2-10","source":"Crossref","is-referenced-by-count":33,"title":["Immunoreactivity for bcl\u20102 protein in cutaneous lymphomas and lymphoid hyperplasias<sup>*<\/sup>"],"prefix":"10.1111","volume":"22","author":[{"given":"Joseph A.","family":"Triscott","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jon H.","family":"Ritter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul E.","family":"Swanson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark R.","family":"Wick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,4,27]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/348334a0"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198711053171904"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V71.4.969.969"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19930701)72:1<231::AID-CNCR2820720141>3.0.CO;2-5"},{"key":"e_1_2_1_6_2","first-page":"225","article-title":"Expression of the bcl\u20102 oncogene protein is not specific for the 14;18 chromosomal translocation","volume":"137","author":"Pezzella F","year":"1990","journal-title":"Am J Pathol"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V80.8.2044.2044"},{"key":"e_1_2_1_8_2","first-page":"108","article-title":"Expression of bcl\u20102 oncogene protein in malignant lymphomas, including Hodgkin's disease and non\u2010Hodgkin's lymphomas of T cell phenotype","volume":"1","author":"Said JW","year":"1993","journal-title":"Appl Immunohistochem"},{"key":"e_1_2_1_9_2","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1182\/blood.V80.3.768.768","article-title":"bcl\u20102 gene expression in hematopoietic cell differentiation","volume":"80","author":"Mariano MT","year":"1992","journal-title":"Blood"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198806233182502"},{"key":"e_1_2_1_11_2","first-page":"1089","article-title":"Expression of the bcl\u20102 gene product in follicular lymphoma","volume":"140","author":"Gaulard P","year":"1992","journal-title":"Am J Pathol"},{"key":"e_1_2_1_12_2","first-page":"4901","article-title":"Clonal immunoglobulin gene rearrangements and normal T\u2010cell receptor, bcl\u20102 and c\u2010myc genes in primary cutaneous B\u2010cell lymphomas","volume":"49","author":"Delia D","year":"1989","journal-title":"Cancer Res"},{"key":"e_1_2_1_13_2","first-page":"82","article-title":"Rericulohistiocytoma of the dorsum (Crosti's disease) and other B\u2010cell lymphomas","volume":"8","author":"Berti E","year":"1991","journal-title":"Semin Diagn Pathol"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1159\/000418092"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0560.1992.tb00605.x"},{"key":"e_1_2_1_16_2","doi-asserted-by":"crossref","unstructured":"RitterJH AdesokanPN FitzgibbonJF WickMR.Paraffin section immunohistochemistry as an adjunct to morphologic analysis in the diagnosis of cutaneous lymphoid infiltrates J Cutan Pathol1994(in press).","DOI":"10.1111\/j.1600-0560.1994.tb00717.x"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.82.21.7439"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(85)80070-2"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI113235"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-75889-8_26"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V80.4.879.879"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0959-8049(92)90431-Z"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.176.4.1043"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(91)90007-L"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.16.6961"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.1711690408"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0046-8177(93)90209-Y"},{"key":"e_1_2_1_28_2","first-page":"989","article-title":"Different, bcl\u20102 protein expression in high\u2010grade B\u2010cell lymphomas derived from lymph node or mucosa \u2013 associated lymphoid tissue","volume":"139","author":"Villuendas R","year":"1991","journal-title":"Am J Pathol"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V78.4.1062.1062"},{"key":"e_1_2_1_30_2","first-page":"49A","article-title":"bcl\u20102 protein expression in cutaneous lymphoid hyperplasias and follicular lymphomas in the skin","volume":"7","author":"Sangueza OP","year":"1994","journal-title":"Mod Pathol"},{"key":"e_1_2_1_31_2","first-page":"573","article-title":"Primary cutaneous B\u2010cell lymphoma, secondary cutaneous B\u2010cell lymphoma and cutaneous B\u2010cell pseudolymphoma: a histologic, immunohistochemical and molecular genetics analysis of 73 cases","volume":"20","author":"Snow JL","year":"1993","journal-title":"J Cutan Pathol"},{"key":"e_1_2_1_32_2","first-page":"539","article-title":"Expression of bcl\u20102 and Ki\u201067 antigens in cutaneous T\u2010cell lymphoproliferative disorders","volume":"20","author":"Dummer R","year":"1993","journal-title":"J Cutan Pathol"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1159\/000247622"},{"key":"e_1_2_1_34_2","first-page":"182","article-title":"Immunoreactivity for bcl\u20102 protein in peripheral primitive neuroectodermal tumors","volume":"1","author":"Swanson PE","year":"1993","journal-title":"Appl Immunohistochem"},{"key":"e_1_2_1_35_2","first-page":"6940","article-title":"Expression of the protooncogene bcl\u20102 in the prostate and its association with emergence of androgen\u2010independent prostate cancer","volume":"52","author":"McDonnell TJ","year":"1992","journal-title":"Cancer Res"}],"container-title":["Journal of Cutaneous Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0560.1995.tb00732.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0560.1995.tb00732.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T06:19:58Z","timestamp":1698301198000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0560.1995.tb00732.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,2]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1995,2]]}},"alternative-id":["10.1111\/j.1600-0560.1995.tb00732.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0560.1995.tb00732.x","archive":["Portico"],"relation":{},"ISSN":["0303-6987","1600-0560"],"issn-type":[{"value":"0303-6987","type":"print"},{"value":"1600-0560","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,2]]}}}